Unibest 优贝德
← Back to patent-cliff list

CAS 38385-95-4

2-(piperidin-4-yl)-1H-benzo[d]imidazole

CodesBALI-001、BALI-007

Application context (from source-drug indications)

荨麻疹比拉斯汀过敏性鼻炎比拉斯汀皮炎比拉斯汀瘙痒症比拉斯汀湿疹比拉斯汀变应性结膜炎比拉斯汀

Source drugs (routes using this intermediate)

DrugTierExpiry
比拉斯汀BilastineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

比拉斯汀原研路线steps: 3total yield: 3.5 g
2-(piperidin-4-yl)-1H-benzo[d]imidazole4-(2-(4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate2-(2-(4-(2-(4-(1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,5-dihydrooxazole2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,5-dihydrooxazole

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Nantong cGMP Site2-Piperidin-4-yl-1H-benzoimidazole
Pharmaceutical Intermediates
询价询价询价

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.